1 – 10 of 1003
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
In vitro characterisation of a novel rubber contact allergen in protective gloves
- Contribution to journal › Article
-
Mark
Decoding immune heterogeneity in bladder cancer : From cellular cartography to ex vivo models and antibody-based targeting
(2025)
- Thesis › Doctoral thesis (compilation)
-
Mark
Biomarkers for the Early Detection of Pancreatic Ductal Adenocarcinoma
(2025) p.85-100
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
- Contribution to journal › Article
-
Mark
The Progression of Mycosis Fungoides During Treatment with Mogamulizumab: A BIO-MUSE Case Study of the Tumor and Immune Response in Peripheral Blood and Tissue
- Contribution to journal › Article
-
Mark
Altered immune signatures in breast cancer lymph nodes with metastases revealed by spatial proteome analyses
- Contribution to journal › Article
-
Mark
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia
(2025) In Nature Cancer
- Contribution to journal › Article
-
Mark
Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferation
- Contribution to journal › Article
-
Mark
ATOR-4066, a bispecific antibody targeting CD40 and CEACAM5, induces strong myeloid and T cell-dependent tumor immunity and synergizes with PD-1 blockade
(2025) In Cancer immunology research
- Contribution to journal › Article
-
Mark
CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer : Biomarkers associated with outcomes from OPTIMIZE-1
(2025) In Cell Reports Medicine
- Contribution to journal › Article
